SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056178
Filing Date
2021-11-10
Accepted
2021-11-10 16:06:37
Documents
76
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-10q_20210930.htm   iXBRL 10-Q 3777216
2 EX-10.1 pcvx-ex101_97.htm EX-10.1 561686
3 EX-31.1 pcvx-ex311_8.htm EX-31.1 18267
4 EX-31.2 pcvx-ex312_7.htm EX-31.2 17874
5 EX-32.1 pcvx-ex321_9.htm EX-32.1 9406
6 EX-32.2 pcvx-ex322_6.htm EX-32.2 9418
7 GRAPHIC gxbjvoc5fasg000001.jpg GRAPHIC 2070
  Complete submission text file 0001564590-21-056178.txt   11176167

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20210930.xsd EX-101.SCH 67463
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pcvx-20210930_cal.xml EX-101.CAL 58044
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcvx-20210930_def.xml EX-101.DEF 237136
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20210930_lab.xml EX-101.LAB 508552
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20210930_pre.xml EX-101.PRE 399284
13 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-10q_20210930_htm.xml XML 1619119
Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 211396555
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences